Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Provencher

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Gynecologic Oncology|October 3, 2015
Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) IN C Te Grootenhuis, A G J van der Zee, H C van Doorn, et al.
Gynecologic Oncology|June 3, 2025
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancerPremal H Thaker, Debra L Richardson, Andrea R Hagemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian CancerAmit M Oza, Ursula A Matulonis, Angeles Alvarez Secord, et al.
Biopreservation and Biobanking|May 22, 2014
Specimen quality evaluation in Canadian biobanks participating in the COEUR repositoryCécile Le Page, Martin Köbel, Manon de Ladurantaye, et al.
Brain : a Journal of Neurology|June 14, 2015
Recessive nephrocerebellar syndrome on the Galloway-Mowat syndrome spectrum is caused by homozygous protein-truncating mutations of WDR73Robert N Jinks, Erik G Puffenberger, Emma Baple, et al.
American Journal of Ophthalmology|June 16, 2024
A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma SurgeryRon D Hays, Michelle E Tarver, Malvina Eydelman, et al.
Journal of Medical Genetics|September 5, 2006
The contribution of germline rearrangements to the spectrum of BRCA2 mutationsF Casilli, I Tournier, O M Sinilnikova, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 30, 2020
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesEun Young Kang, Dane Cheasley, Cecile LePage, et al.
Nature Communications|September 4, 2019
The molecular origin and taxonomy of mucinous ovarian carcinomaDane Cheasley, Matthew J Wakefield, Georgina L Ryland, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Gynecologic Oncology|October 3, 2015
Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) IN C Te Grootenhuis, A G J van der Zee, H C van Doorn, et al.
Gynecologic Oncology|June 3, 2025
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancerPremal H Thaker, Debra L Richardson, Andrea R Hagemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian CancerAmit M Oza, Ursula A Matulonis, Angeles Alvarez Secord, et al.
Biopreservation and Biobanking|May 22, 2014
Specimen quality evaluation in Canadian biobanks participating in the COEUR repositoryCécile Le Page, Martin Köbel, Manon de Ladurantaye, et al.
Brain : a Journal of Neurology|June 14, 2015
Recessive nephrocerebellar syndrome on the Galloway-Mowat syndrome spectrum is caused by homozygous protein-truncating mutations of WDR73Robert N Jinks, Erik G Puffenberger, Emma Baple, et al.
American Journal of Ophthalmology|June 16, 2024
A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma SurgeryRon D Hays, Michelle E Tarver, Malvina Eydelman, et al.
Journal of Medical Genetics|September 5, 2006
The contribution of germline rearrangements to the spectrum of BRCA2 mutationsF Casilli, I Tournier, O M Sinilnikova, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 30, 2020
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesEun Young Kang, Dane Cheasley, Cecile LePage, et al.
Nature Communications|September 4, 2019
The molecular origin and taxonomy of mucinous ovarian carcinomaDane Cheasley, Matthew J Wakefield, Georgina L Ryland, et al.
Pageof 11